Answers are grounded in this paper and cite their sources.
Recent advances explore how 3D bioprinted models predict responses in cancer therapies, indicating their potential for personalized medicine.
We discuss the potential of 3D bioprinted models for predicting patient-specific responses in developing tailored therapies towards precision oncology.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: